The Stanford Innovative Medicines Accelerator (IMA) is now accepting proposals for projects that address two key challenges in antibody and protein drug development: the identification of drug candidates and their optimization into clinical leads.
The Stanford SPARK program supports the discovery and development of novel therapeutics and diagnostics that address unmet medical needs by offering funding, education and project-specific mentorship.
For innovators whose work has progressed towards developing solutions for specific commercial applications. The awards provide advisory support and funding to enable the move from research innovation to technology transfer or startup funding.
Sarafan ChEM-H is accepting applications from Stanford labs that would like to leverage the Chemoproteomics group at the Nucleus to advance therapeutic approaches in cancer, with a preference for EGFR-mutant lung cancer.
The Wu Tsai Human Performance Alliance invites proposals on athletic performance, injury prevention, and injury recovery to discover the biological principles that govern optimum performance, from the molecular level to the whole body.
This seed grant program provides awards of up to $25k to help faculty expand their international network of researchers through early-stage research projects.
Stanford HAI seeks proposals that support new, ambitious, and speculative ideas in AI with the objective of getting initial results. We expect to award approximately 25 grants, up to $75,000.
C-ShaRP welcomes collaborative proposals for educational efforts that leverage Stanford’s shared research facilities to enrich scientific learning journeys with hands-on experiences, facilitating research progress and promoting real-world skills.
